PSMA

Open Access
A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy
Phillip H. Kuo, Don C. Yoo, Ryan Avery, Marc Seltzer, Jeremie Calais, James Nagarajah, Wolfgang A. Weber, Wolfgang P. Fendler, Michael S. Hofman, Bernd J. Krause, Marcia Brackman, Euloge Kpamegan, Samson Ghebremariam, Taylor Benson, Ana M. Catafau and Ayse T. Kendi

Journal of Nuclear Medicine May 25, 2023, 265077; DOI: https://doi.org/10.2967/jnumed.122.265077
You have access
Comparison of ⁶⁸Ga-PSMA-617 PET/CT and ⁶⁸Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study
Romain Schollhammer, Grégoire Robert, Julien Asselineau, Mokrane Yacoub, Delphine Vimont, Nicolas Balamoutoff, Franck Bladou, Antoine Bénard, Elif Hindié, Henri de Clermont Gallerande and Clément Morgat

Journal of Nuclear Medicine March 1, 2023, 64 (3) 379-385; DOI: https://doi.org/10.2967/jnumed.122.263889
You have access
Predicting Outcomes of Indeterminate Bone Lesions on ¹⁸F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer
Tim E. Phelps, Stephanie A. Harmon, Esther Mena, Liza Lindenberg, Joanna H. Shih, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke and Baris Turkbey

Journal of Nuclear Medicine March 1, 2023, 64 (3) 395-401; DOI: https://doi.org/10.2967/jnumed.122.264334
Open Access
PSMA-GCK01 - A Generator-Based ^99mTc-/¹⁸⁸Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine February 9, 2023, jnumed.122.264944; DOI: https://doi.org/10.2967/jnumed.122.264944
You have access
A 2022 International Survey on the Status of Prostate Cancer Theranostics
Thomas Beyer, Johannes Czernin, Lutz Freudenberg, Frederik Giesel, Marcus Hacker, Rodney J. Hicks and Bernd J. Krause

Journal of Nuclear Medicine January 1, 2023, 64 (1) 47-53; DOI: https://doi.org/10.2967/jnumed.122.264298
You have access
¹⁷⁷Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
Thorsten Derlin, Liam Widjaja, Rudolf A. Werner and Frank M. Bengel

Journal of Nuclear Medicine January 1, 2023, 64 (1) 54-58; DOI: https://doi.org/10.2967/jnumed.122.264293
You have access
Feasibility of ^99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer

Journal of Nuclear Medicine January 1, 2023, 64 (1) 59-62; DOI: https://doi.org/10.2967/jnumed.122.263892
You have access
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on ⁶⁸Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx and Berlinda J. de Wit-van der Veen

Journal of Nuclear Medicine January 1, 2023, 64 (1) 63-68; DOI: https://doi.org/10.2967/jnumed.122.264101
You have access
From Concept to Regulatory Drug Approval: Lessons for Theranostics
Marlon Perera and Michael J. Morris

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1793-1801; DOI: https://doi.org/10.2967/jnumed.121.263301
You have access
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
Ken Herrmann, Luca Giovanella, Andrea Santos, Jonathan Gear, Pinar Ozgen Kiratli, Jens Kurth, Ana M. Denis-Bacelar, Roland Hustinx, Marianne Patt, Richard L. Wahl, Diana Paez, Francesco Giammarile, Hossein Jadvar, Neeta Pandit-Taskar, Munir Ghesani and Jolanta Kunikowska

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1836-1843; DOI: https://doi.org/10.2967/jnumed.122.264321

Main menu

User menu

Search

PSMA

Pages